FDA Inspection 1241987 — Prof. Richard Van Zyl-Smit
The FDA completed an inspection of Prof. Richard Van Zyl-Smit on Jun 7, 2024 in Cape Town. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 7, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Cape Town (South Africa)
Additional Details
Clinical Investigator (CI)